ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.

Profile

Company Names

ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.

Addresses

C/O ADJUVANT CAPITAL, L.P., 501 FIFTH AVENUE, SUITE 1404, NEW YORK, NY 10017

445 5TH AVENUE, #20D, NEW YORK, NY 10016

Phone Numbers

917-334-0724

 

Entity Type:

LIMITED PARTNERSHIP

Industry:

PRIVATE EQUITY FUND

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$48,226,950.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2019-12-18 
$48,226,950.00 
$48,226,950.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GLENN 
 
ROCKMAN 
EXECUTIVE OFFICER
IANTECH, INC.   |  INDEVR, INC.   |  ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P.   |  ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.   |  CODAGENIX INC.   |  VITRIVAX, INC.
JENNY 
 
YIP 
EXECUTIVE OFFICER
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P.   |  ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.   |  STACK DIAGNOSTICS, INC.   |  CHROMACODE, INC.   |  54GENE, INC.   |  ANTIVA BIOSCIENCES, INC.   |  EVOFEM BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-02-23
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2019-12-18 
2020-01-17
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2019-12-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#